Actogen aims to become a market elader in the discovery of novel drugs for the treatment of mental diseases, using its unique high throughput in vivo screening technology.

Broadband entertainment services.

To exploit a unique database of Amazonian medicinal plants to develop novel medicines with an initial focus on women's health needs.

Angiomics is a start-up biopharmaceutical company with the mission of discovering drugs from medicinal plants. The focus will be on accelerating wound healing. At present, the $5 billion global wound care market consists mainly of products that, at best, only create environments conducive to healing. The future of the wound care market lies in the promise of products that go beyond facilitative wound repair and actively accelerate the healing process. Angiomics already possesses a patent-protected technology that accelerates a key step in wound healing. Founded by three PhD students at the Unversity of Coventry, Angiomics is determined to stay in the lead by employing cutting-edge technologies in the drug discivery process.

The concept is an intelligent, modular, transportation and sorting system.

AromaFlora aims to grow the finest quality Fairtrade fragranced roses in Kenya and deliver them to your door here in Europe. AromaFloras strong focus on corporate social responsibility and our use of renewable energy sources and environmentally friendly techniques will help establish the AromaFlora brand and enable the production of Fairtrade approved roses targeted at the 340 million European rose market. Revenues generated from these roses will fund the in-house development of AromaFloras fragrance technology, leading to the generation of our value added roses. AromaFloras Fast Flower Model will further increase profit margins by excising the middle men.

ArrayScreen will exploit 'microarray' or '2DNA Chip' technology and the information provided by the Human Genome Project to develop revolutionary diagnostic tests to predict a variety of medical conditions such as cardiovascular disease.

PBT hold the right to a novel technology that allow first trimester screening for foetal genetic diseases, such as Down's Syndrome, using a low-risk, low-cost blood test.

BioMask Application (BMA) intends to manufacture customised laser-resistant adhesive biopolymer barriers that protect undamaged skin from intense laser treatment.

A fabless semiconductor company, BOPPHY Technologies will design, develop and market innovative digital integrated circuits for broadband communications over the existing electrical infrastructure. Broadband over powerlines (BOP) gives customers high-speed internet access through the existing power grid network and enables utility companies to add data services to their offering. By exploiting state of the art modulation and coding techniques, our implementation of the physical layer (PHY) will ease competition against other broadband services by increasing current data rates of cable and DSL by up to a factor of 10.

A solution as to how to cool a beverage rapidly, and how to enjoy a cold drink on the go when cooling facilities are not available.

Recent work at the University of Coventry has led to the discovery of a new supercapacitive material capable of storing 10 times more electrical energy than competing materials. Consequently, the patent-protected Cam-Cap supercapacitor is able to combine the large energy storage capacity of batteries with the rapid power delivery capabilities of capacitors to meet new customer needs that cannot be satisfied using other existing energy storage materials. The advantages of the Cam-Cap supercapacitors are particularly apparent in the rapidly expanding high performance energy storage markets associated with environmentally friendly alternatives in the transport and power generation industries.

Cambfix is a business prospect that provides innovative, high quality medical devices for use in orthopaedic and trauma surgery. Every year there are 1.5 million ankle and wrist fractures, which costs the healthcare industry $3 billion. Over one third of these cases develop a complication during treatment. Cambfixs first generation products have a patentable technology that addresses these complications in their entirety and can thereby save the healthcare industry $800 million in ankle and wrist fractures alone. The product pipeline also includes fixators for other fractured bones, soft tissue corrections, paediatric, veterinary and military use. Our products are non-invasive, offer a superior mode of treatment and will reduce patient morbidity by decreasing complications to less than 1%.

To provide a software solution for in silico drug discovery and prediction of drug side effects. Ccnet exploit the explosion of post-genomic data produced by high-throughput technologies such as DNA microarrays and portein chips.

The market for laboratory supplies is large and growing. It is also increasingly competitive. We plan to use proprietary technology to substantially increase the productivity of laboratory basesd researchers. This technology platform will provide unique products enabling significant cross-selling, which will confer a major competitive advantage in this high value added market.

Coventry InnoVision is about the automatic generation of 3D models from real objects.

CIV will be set up to exploit cutting-edge Computer vision technology that will make the acquisition of 3D models significantly quicker, cheaper and more realsitic than currently possible.

Coventry Laboratory Innovatios' novel VirginCollector product will allow for automation of the virgin fruit fly collection process, providing large savings in time and efficiency for researchers in this field.

Coventry Performance Solutions (CPS) has identified a current market opportunity to undertake performance improvement using advanced control technology in the pulp & paper and batch fermentation industries. In the past seven years advanced control has matured in academia and can now handle the fast, unstable and nonlinear dynamics seen in these industries. The close partnership with the University of Coventry Control Group, who have pioneered many of these advancements, as well as the 35 years industrial experience of their Chief Executive Officer, makes CPS ideally positioned to bring the most recent developments to new process sectors.

IT

To provide effective cognitive test, measures and treatments for psychological challenges.

c2i aims to become a world-leading carbon fibre composites design, engineering and production company. It will enjoy high growth and margins due to its low cost Slovak manufacturing base and low cost production processes yielding 30-50% total cost savings in a $42 billion industry. c2i will design and manufacture its own products, the first being a revolutionary carbon fibre wheelchair. c2i will also pursue subcontracting for the aerospace, automotive, boat and leisure industry. c2is first contract is a revolutionary prefabricated palm tree house aimed at 5 star hotels and wealthy families gardens.

There are 130,000 patients worldwide who undergo peritoneal kidney dialysis using 200 million consumable fluid packs annually. Users under the current system have a 1 in 200 chance of getting a serious infection every year during the connection process. Due to the poor design of current systems, patients experience gatal infections, irritating rashes, general discomfort and difficulty in operating the critical equipment. ConnectEases technology dramatically reduces the rate of infection and training time required, whilst addressing the issues of patient comfort and ergonomics. Expected revenues are 500 million by 2010 and 1.3 billion by 2015.

Apply the latest power electronic technologies to solar energy applications, to produce cost effective solar products for developed and developing countries.

EnvAls novel technology is capable of recycling 100% of the waste obtained from post consumer drink cartons (i.e. Tetra Paks). The process recovers clean aluminium that can be sold to the aluminium industry and generates oils and gases suitable for heat or electricity production. EnvAl will contribute to the sustainable development of society by generating profit and by reducing the amount of materials that are currently being landfilled. EnvAl is seeking the partnership of an early stage investor who will provide financial backing to finish building the first demonstration equipment, and then remain with the company to realise its full potential.

Future Vision will help companies protect themselves against weather-related risks using weather derivatives. The weather derivatives market is an $8 billion market it has shown explosive growth over the last three years, especially in the US. Next year it is expected to double this growth in Europe. Future Vision will meet its clients' requirements for weather risk management by delivering advanced software solutions and by providing value-added professional services. Given the constantly changing environment, Future Vision will continue looking after its clients' needs by developing new products.

No public summary available.

GEO has developed a novel, in-situ testing technique applicable to several niche construction quality control (CQC testing market, estimated at over 35m pa) within the rapidly growing environmental industry.

A mobile phone charger that operates using a dynamo mechanism when cycling.

A 3D display that requires no head gear.

Development of scientific simulation programmes for astrophysics.

Software/wireless

Light Blue Optics (LBO) is a dynamic, privately-owned company, developing miniature projection systems.

LBO’s patented holographic laser projection technology delivers full colour, high-quality video images that remain in focus at all distances. The technology’s efficiency, small form factor, robustness and cost advantages make it ideally suited for deployment in multiple markets including automotive, digital signage and consumer electronics.

LBO is funded by a group of investors including 3i plc., Earlybird Ventures and Capital-E.

Linguit is a human language technology company whose first product is Nuggets, an SMS based internet search engine. Nuggets wallows mobile phone subscribers to text their questions to a service number and receive answers within seconds. The market for premium information services is expected to grow to $100 million by 2006 in the UK alone, a fraction of the billion dollar information services market. Other companies provide SMS based question and answer services but use people to search the internet, whereas Nuggets is automated. Nuggets is much faster than these competing services and costs much less to provide.

M-Rputer offer a range of value-added products/services to telecom carriers, such as traffic information and navigation SMS text messages, and a mobile callback service.

A patentable solution to provide self-erecting scaffolding towers. Previously known as AccelErector.

Depression and anxiety are poorly diagnosed in primary care. There is a clear need for a reliable, convenient diagnostic system for use in this setting. MoodLab combines cutting-edge technology with statistical models in a hand-held device to provide a reliable, office-based, diagnostic system for depression and anxiety for use I nprimary and specialist care.

MultiProSys is a Proteomics company positioned as a tools provider in the drug discovery value chain.

To provide generic and efficient protein refolding technology to facilitate the production of recombinant proteins using bacteria hosts.

data/IT

Owlstone introduces an innovative gas spectrometry technology shrinking the full functionality of conventional trace analysis instrumentation onto a chip.

Digital systems for scientists

To launch the next generation of frequency standard instruments modules providing an affordable solution in telecommunications, research and other high technology areas that require very accurate time on frequency standards.

Schmode's first product, the Light Tile, will make the surfaces of a room glow. As the technology develops, surfaces will change colour. Schmode will offer the first off-the-shelf electroluminescent product for designers or commercial and personal spaces.

SimuGen is a gene profiling company applying techniques from computational biology and wet lab research to provide cheaper ethical healthcare. SimuGen creates value by bringing to market an analytically powerful solution to ascribe the toxicity of compounds, thereby extensively reducing downstream animal testing. This transcribes into vastly reduced costs and timelines in preclinical testing. Protection of our assets will be mediated through our proprietary databank of gene expression profiles and will be reinforced by future patents on our gene combinations and algorithms. As a platform technology our solution is easily transferable to a range of other markets, including personal care.

Imagine a world with wireless power! Zap Wireless Technologies is developing a range of products (ZapPad, ZapCell, ZapDevices, ZapSystems) to replace disposable batteries and power cables in mobile phones, laptops and a range of other consumer and industrial applications. No disposable batteries, no wires, just ZAP! Founded by a team of three with outstanding expertise in wireless technologies, business and product innovation, Zap Wireless Technologies has built a prototype and is seeking first-round funding to support further R&D activities.

Collection and log-term storage of umbilical cord blood stem cells for the benefit of the newborn child and their family. Additional business activities will include viral screening and tissue-typing (genetic identification) of the colleced stem cells.

To transform logistics through location technology.

Tritech will leverage productivity from average users to business users by seamlessly integrating mobile communications with the computing world. This is done by providing a Platform for Ubiquitous Mobile Applications (PUMA) to support customised applications tailored towards different devices ranging from embeded devices to sophisticated devices supporting connectivity.

Weather Informatics provides bespoke forecast products, based on our proprietary WRIST package to enable weather-sensitive business to greatly improve their management of weather-related risks. Some 70% of all businesses, and as much as $1000bn of the US economy alone, are significantly exposed to take such risks. New financial products, 'weather derivatives', can be used by exposed bsuinesses to manage their risks. Over 4000 weather derivative contracts have been taken out thus far, with over $10bn in notional risk transferred. The customer-specific products taken out by Weather Informatics will give forecasts for use in the pricing of weather derivatives and will offer significant competitive advantage to our customers.